RxDoctor Payments Data

Joseph Zabilski, MD

Orthopaedic Surgery · Plymouth, MANPI 1710934500

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,651 of the $3,166 with a category attached, or 83.7%. Stryker accounts for 85.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $1,280 and has fallen 88.2% since, to $151 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in MA, where the typical reported total is $3,637.

$3,166in general payments, 2019–2025

Across 56 payments — averaging $56.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Abbott$110
  • Pacira Therapeutics, Inc.$103
  • Johnson & Johnson$87
  • Ferring Pharmaceuticals Inc.$57
  • Bioventus LLC$49
  • plus $63 from 3 others

What the payments were for

  • Travel & lodging$51616%
  • Food & beverage$2,65184%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,166 in reported general payments places this provider in the 45th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$354,761
Medicare patients
671
Services billed
3,662

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl28$71
Tramadol Hcl31$58
Ondansetron OdtOndansetron13$55
Meloxicam22$25

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Plymouth

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →